Official UK procurement notice
UKHSA_Scientific- Provision of Viral Antigens
Authority: Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency (Central government)
What is being bought
Published requirement descriptionUK Health Security Agency (UKHSA) has awarded a contract to the Native Antigen Company Limited for the supply of viral antigens.
CPV: Antineoplastic and immunomodulating agents
The lotProcurement structure
single lot · value publishedLot #1AwardedPublished value£240,000
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
- Price
Procedure terms & legal framework
From the official record- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- No (one-off requirement)
- First published
- 14 May 2024, 14:35 BST
- Last source update
- 20 Aug 2024, 14:49 BST
- Award evaluation window
- 14 May 2024 – …
- Authority reference
C234400- FTS notice number
2024/S 000-026500- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-045979Find a Tender
How it was run
Official noticeTender documents are also served through a separate tool: https://health-family.force.com/s/Welcome ↗
- Submission deadline
- 14 Jun 2024, 12:00 BST
- Submission channel
- {"electronicSubmission","written"}
- Accepted languages
- en
- Bids opened
- 14 May 2024, 14:30 BST
Timeline
14 May 2024 → 30 Aug 2024 · 5 dates- Bids opened14 May 2024, 14:30 BST
- Submission deadline14 Jun 2024, 12:00 BST
- Contract starts1 Aug 2024, 00:00 BST
- Notice published20 Aug 2024, 14:49 BST
- Bids must remain valid until30 Aug 2024, 23:59 BST
Notice history
1 event · 2 releases on Find a Tender- Status changed to complete20 Aug 2024, 14:49 BST
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| The Native Antigen Company (LGC Group)SME | £240,000 † | — | Awarded |
Contracts
Contract 026500-2024-1 · The Native Antigen Company (LGC Group)SME
- Signed
- 19 Aug 2024
- Value
- £240,000
- Period
- … – 31 Jul 2027
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids · 1 electronic | 1 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- High CourtMediation bodyReview bodyReview contact point
Bidders & participating suppliers
1 commercial party on the notice- The Native Antigen Company (LGC Group)Awarded supplier
Official documents & specifications (2)
Official links; attachments are not copiedTender pack and attachments
- Economic and financial selection criteria
- Technical selection criteria